KILL iXCells Biotechnologies Reaches iPSC Line Delivery Milestone in Collaboration With Global Biotechnology Company

March 13, 2026 at 11:08 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

iXCells Biotechnologies USA, Inc. requests that their press release NewsItemId: 20260311932205 issued March 11, 2026 “iXCells Biotechnologies Reaches iPSC Line Delivery Milestone in Collaboration With Global Biotechnology Company” be killed.

The release was issued in error by iXCells Biotechnologies USA, Inc.

A replacement release will not be issued.

Contacts

Media contact:
Dr Ben Rutter
Zyme Communications
Tel: +44(0)7920 770 935
Email: ben.rutter@zymecommunications.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	238.58	-5.61 (-2.30%)
AAPL	293.40	+2.85 (0.98%)
AMD	452.98	-22.53 (-4.74%)
BAC	54.74	+0.32 (0.60%)
GOOG	354.45	-7.84 (-2.16%)
META	572.98	-11.61 (-1.99%)
MSFT	400.45	-2.96 (-0.73%)
NVDA	201.58	-6.61 (-3.17%)
ORCL	203.85	-1.96 (-0.95%)
TSLA	382.94	-13.74 (-3.46%)

Symbol

Price

Change (%)

AMZN

238.58

-5.61 (-2.30%)

AAPL

293.40

+2.85 (0.98%)

AMD

452.98

-22.53 (-4.74%)

BAC

54.74

+0.32 (0.60%)

GOOG

354.45

-7.84 (-2.16%)

KILL iXCells Biotechnologies Reaches iPSC Line Delivery Milestone in Collaboration With Global Biotechnology Company

Contacts

More News

Recent Quotes